Stroke Prevention in Sickle Cell Anemia (STOP 2)

Clinical trial NCT00006182 · COMPLETED

Trial details

NCT number: NCT00006182
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Blood Disease Cerebrovascular Accident Anemia, Sickle Cell

Start date: 2000-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.